Ioannis Boukovinas

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3.2K citations · Full text

Medicine, Oncology, Cancer Pharmacology +11

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

Axel Grothey, Alberto Sobrero, Anthony F. Shields et al. · New England Journal of Medicine · 2018 · 1.1K citations · Full text

Medicine, Oncology, Pharmacology +16

Longitudinal Cohort Study of Risk Factors in Cancer Patients of Bisphosphonate-Related Osteonecrosis of the Jaw

Konstantinos Vahtsevanos, Αthanassios Kyrgidis, Evgenia Verrou et al. · Journal of Clinical Oncology · 2009 · 464 citations

Medicine, Oncology, Cancer Prevention +8

Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials

Thierry André, Jeffrey A. Meyerhardt, Timothy Iveson et al. · The Lancet Oncology · 2020 · 298 citations

Medicine, Biostatistics, Oncology +13

Bisphosphonate-Related Osteonecrosis of the Jaws: A Case-Control Study of Risk Factors in Breast Cancer Patients

Αthanassios Kyrgidis, Konstantinos Vahtsevanos, Georgios Koloutsos et al. · Journal of Clinical Oncology · 2008 · 224 citations

Dentistry, Oncology, Breast Oncology +11